Results 201 to 210 of about 35,539 (289)

Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine. [PDF]

Open Forum Infect Dis
Alonge OD, Marin M, Hickman CJ, Sowers SB, Chen MH, Hao L, Mercader S, El-Badry E, McClure DL, Icenogle JP, Sugerman DE, Crooke SN, Nguyen HQ.   +12 more
europepmc   +1 more source

Safe Measles, Mumps and Rubella Vaccine Administration in Atopic Children with High Levels of Egg White-Specific IgE Antibody

, 2011
Katarina Stavrikj, Sonja Peova, Aleksandar Petlickovski, Irena Kondova Topuzovska, Мирко Спироски   +4 more
openalex   +2 more sources

Looking in the medicine cabinet: methods for using real-world data to assess the impact of measles, mumps and rubella (MMR) and recombinant adjuvanted varicella-zoster vaccines on coronavirus disease 2019 (COVID-19) prevention and case fatality

, 2021
Douglas McNair, Hao Hu, Casey Selwyn
openalex   +2 more sources

The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study.

Lancet. Infectious Diseases (Print), 2016
John W. Glasser, Zhilan Feng, Saad B Omer, Philip J. Smith, Lance E. Rodewald   +4 more
semanticscholar   +1 more source

Art of prevention: Our approach to the measles-mumps-rubella vaccine in adult patients vaccinated against measles before 1968 on biologic therapy for the treatment of psoriasis. [PDF]

Int J Womens Dermatol, 2020
Worth A, Waldman RA, Dieckhaus K, Rothe MJ.   +3 more
europepmc   +1 more source

Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin

, 2012
Gabriela Rüger, Giovanni Gabutti, H. C. Rümke, Lars Rombo, Enrique Bernaola, Javier Díez‐Domingo, Federico Martinón‐Torres, Birthe Høgh, Antreas Konstantopoulos, Anne Fiquet, Stéphane Thomas, Cécile Eymin, Martine Baudin   +12 more
openalex   +1 more source

Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8–9 months-old Indian children

, 2022
Krishna Mohan Vadrevu, Raju Dugyala, N. Mahantashetti, Vasant Khalatkar, Krishna Murthy, Sandeep Mogre, Monjori Mitra   +6 more
openalex   +1 more source

Critical appraisal of the literature reporting association between measles-mumps-rubella vaccine and autism [PDF]

, 2016
Καραΐσκου, Μαριάνθη
core   +1 more source

Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age. [PDF]

Vaccine, 2020
Haralambieva IH, Ovsyannikova IG, Kennedy RB, Goergen KM, Grill DE, Chen MH, Hao L, Icenogle J, Poland GA.   +8 more
europepmc   +1 more source